title: CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes.
abstract: During acute inflammation, monocytes are essential in abolishing invading micro-organisms and encouraging wound healing. Recruitment by CC chemokines is an important step in targeting monocytes to the inflamed tissue. However, cell surface expression of the corresponding chemokine receptors is subject to regulation by various endogenous stimuli which so far have not been comprehensively identified. We report that the platelet-derived CXC chemokine ligand 4 (CXCL4), a known activator of human monocytes, induces down-regulation of CC chemokine receptors (CCR) 1, -2, and -5, resulting in drastic impairment of monocyte chemotactic migration towards cognate CC chemokine ligands (CCL) for these receptors. Interestingly, CXCL4-mediated down-regulation of CCR1, CCR2 and CCR5 was strongly dependent on the chemokine's ability to stimulate autocrine/paracrine release of TNF-α. In turn, TNF-α induced the secretion CCL3 and CCL4, two chemokines selective for CCR1 and CCR5, while the secretion of CCR2-ligand CCL2 was TNF-α-independent. Culture supernatants of CXCL4-stimulated monocytes as well as chemokine-enriched preparations thereof reproduced CXCL4-induced CCR down-regulation. In conclusion, CXCL4 may act as a selective regulator of monocyte migration by stimulating the release of autocrine, receptor-desensitizing chemokine ligands. Our results stress a co-ordinating role for CXCL4 in the cross-talk between platelets and monocytes during early inflammation.
authors.affiliation: Research Center Borstel, Borstel, Germany.
authors.forename: Franziska
authors.initials: F
authors.lastname: Schwartzkopff
authors.forename: Frank
authors.initials: F
authors.lastname: Petersen
authors.forename: Tobias Alexander
authors.initials: TA
authors.lastname: Grimm
authors.forename: Ernst
authors.initials: E
authors.lastname: Brandt
mesh_terms: D019898:Autocrine Communication; D001792:Blood Platelets / Q000276:immunology / Q000378:metabolism*; D002465:Cell Movement; D002478:Cells, Cultured; D054405:Chemokine CCL3 / Q000235:genetics / Q000378:metabolism; D054407:Chemokine CCL4 / Q000235:genetics / Q000378:metabolism; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000276:immunology; D009000:Monocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D010978:Platelet Factor 4 / Q000235:genetics / Q000378:metabolism*; D054389:Receptors, CCR1 / Q000235:genetics / Q000378:metabolism; D054390:Receptors, CCR2 / Q000235:genetics / Q000378:metabolism; D019713:Receptors, CCR5 / Q000235:genetics / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000276:immunology / Q000378:metabolism*
chemical_list: D054405:Chemokine CCL3; D054407:Chemokine CCL4; D054389:Receptors, CCR1; D054390:Receptors, CCR2; D019713:Receptors, CCR5; D014409:Tumor Necrosis Factor-alpha; D010978:Platelet Factor 4